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OBJECTIVES This study investigated whether temperature measurements are influenced by blood flow.
BACKGROUND Previous ex vivo studies showed marked thermal heterogeneity in atheromatic plaques. In
stable lesions, however, trivial in vivo temperature variations are recorded, perhaps due to the
“cooling effect” of blood flow.
METHODS Eighteen patients with effort angina were studied. Coronary flow velocity was continuously
recorded; over another guidewire, temperature measurements were performed at the proximal
vessel wall and at the lesion before, during, and after complete interruption of blood flow by
inflation of a balloon. The Tp was assigned as the difference between the proximal vessel
wall temperature and the maximal temperature during and after balloon inflation. The Tl
was assigned as the difference between the atherosclerotic plaque and the proximal vessel wall.
RESULTS The procedure was not complicated. During and after complete interruption of flow, Tp was
0.012  0.01°C and 0.006  0.01°C (p  0.001), respectively. The Tl was 0.08 
0.04°C at baseline and went to 0.18  0.05°C (60.5  14.1% increase) during and 0.08 
0.04°C after flow interruption (p  0.001). The Tl was greater than Tp during and after
impairment of flow (p 0.001). A correlation between the baseline average peak velocity and
Tl during flow interruption was found (R  0.57, p  0.01). In seven patients thermal
heterogeneity was not detected at baseline, and during balloon inflation Tl increased by 76.0
 8.4%.
CONCLUSIONS. Thermal heterogeneity is underestimated in atherosclerotic plaques in patients with effort
angina. Potential in vivo underestimation of heat production locally in human atherosclerotic
is due to the “cooling effect” of coronary blood flow. (J Am Coll Cardiol 2003;41:403–8)
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Both ex vivo and in vivo studies have demonstrated thermal
heterogeneity in human atherosclerotic plaques (1,2). Ther-
mal heterogeneity is increased in unstable atherosclerotic
plaques compared to stable plaques (1). Patients with effort
angina have decreased thermal heterogeneity compared to
patients with acute coronary syndromes. Recent studies have
also shown that, by dietary or pharmacologic intervention,
thermal heterogeneity may be decreased (3,4). In an exper-
imental model, reduction of thermal heterogeneity of aortic
atherosclerotic plaques was accomplished after cholesterol
lowering (3). In humans, administration of 3-hydroxy-3-
methylglutaryl–coenzyme A reductase inhibitors (statins)
was accompanied by decreased thermal heterogeneity in
coronary atherosclerotic plaques (4).
The identification of lesions with thermal heterogeneity
is also important for the risk stratification after percutaneous
coronary intervention. Patients with treated lesions with
increased temperature have unfavorable prognosis compared
to patients without increased thermal heterogeneity in
culprit lesions (5).
In several significant lesions, however, temperature vari-
ations cannot be detected or trivial changes are recorded.
Especially in patients with effort angina, in only 20% of
them was thermal heterogeneity found (1). However, the ex
vivo temperature variations were greater than the reported
in vivo thermal heterogeneity (2).
A possible mechanism for the in vivo underestimation of
thermal heterogeneity within human atherosclerotic plaques
is the effect of blood flow. The “cooling effect” of blood flow
on temperature measurements has not been investigated.
The aim of this study was to investigate whether tempera-
ture measurements are influenced by blood flow.
METHODS
Study population. Inclusion criteria were patients suffering
from effort angina with single lesion 20 mm in length in
a major native coronary artery with proximal reference vessel
diameter 2.5 mm.
Patients under medication with corticosteroids or non-
steroidal anti-inflammatory drugs except for aspirin, were
excluded from the study. Moreover, patients with intercur-
rent inflammatory or neoplastic condition likely to be
associated with an acute-phase response were not enrolled
in the study. Exclusion criteria also included multivessel
disease and myocardial infarction less than one month
before intervention.
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According to these criteria the study population consisted
of 18 consecutive patients. Baseline demographic and pro-
cedural variables were recorded and entered prospectively in
a prespecified database. The study protocol was approved by
the institutional ethical committee, and each patient pro-
vided written informed consent.
Thermography catheter. The design and construction
characteristics of the coronary thermography catheter
(Epiphany, Medispes SW A.G., Zug, Switzerland) have
been previously described in detail (1,4–5). In brief, the
technical characteristic of the polyamide thermistor include
1) temperature accuracy of 0.05°C, 2) time constant of 300
ms, 3) spatial resolution of 0.5 mm, and 4) linear correlation
of resistance versus temperature over the range of 33° to
43°C. Opposite the thermistor is a hydrofoil specifically
designed to ensure contact of the thermistor on the vessel
wall.
Procedure. The culprit lesion of interest was outlined in
2 well-opacified views with biplane angiography. These
projections were obtained before and after the procedure.
The study protocol is summarized in Figure 1.
Through a 7F guiding catheter, a conventional guidewire
and a 0.014-in. Doppler-tipped guidewire (Flowire, Car-
diometrics, Mountain View, California) were advanced
distal to the target lesion. The second guidewire was
positioned approximately 3 cm distal to the lesion in the
target vessel and positioned until an optimal and stable
Doppler signal, not in the proximity of a side branch, was
obtained. The instantaneous coronary flow velocity and the
electrocardiogram were continuously displayed throughout
the study and recorded on videotape. Average peak velocity
(cm/s) was derived automatically by the integrated signal-
analyzing computer (6–8).
Five minutes after any contrast injection, the thermogra-
phy catheter was advanced over the guidewire to the target
vessel, and blood temperature was measured when the
thermistor had just emerged from the tip of the guiding
catheter without being in contact with the vessel wall.
Thereafter, temperature was recorded at the proximal non-
diseased vessel wall—evaluated by intravascular ultrasound
(Endosonics Europe B.V., Ulestradten, The Nether-
lands)—and the most frequent temperature was designated
the proximal vessel wall temperature. Afterwards, tempera-
ture recordings at the atherosclerotic lesion were performed.
A balloon-catheter (Cronus, Medispes SW A.G., Zug,
Switzerland) was then introduced over the Doppler-tipped
guidewire to a site just proximal to the lesion; temperature
of the atherosclerotic plaque was continuously recorded. To
avoid injury, the maximum pressure that was scheduled for
interruption of flow was 3 atm. Therefore, the selection of
the diameter of the balloon was 0.5 mm larger than the
diameter of the proximal reference vessel. The balloon was
then progressively inflated until flow was completely inter-
rupted. The balloon was inflated with a mixture of contrast
medium and normal saline at 37°C (Fig. 2). After balloon
deflation, the balloon catheter was withdrawn and temper-
ature was continuously recorded at the lesion. The balloon
catheter was then advanced at the proximal nondiseased
segment in which baseline temperature measurements were
performed, and the thermography catheter was withdrawn
proximally. The thermistor of the thermography catheter
was placed just distal to the balloon. The balloon was
progressively inflated until the flow was completely inter-
rupted. After balloon deflation, the balloon catheter and the
thermography catheter were withdrawn and all patients
underwent stent (Zeus, Medispes SW A.G., Zug, Switzer-
land) implantation using standard technique. Coronary flow
velocity was also recorded during and after stent placement.
In all patients, creatine kinase (CK) and creatine
kinase-MB fraction (CK-MB) were measured at 6 and 12 h
after the procedure. The Q-wave myocardial infarction
(MI) was documented by the presence of new Q waves of at
least 0.04 in duration and a CK level, with a positive
CK-MB fraction, at least twice the upper limit of normal.
Non–Q-wave MI was defined as an elevation of CK greater
than twice the normal value, with a positive CK-MB
fraction, without development of new Q-wave.
Abbreviations and Acronyms
CK  creatine kinase
CK-MB  creatine kinase-MB fraction
MI  myocardial infarction
Tl  difference between the atherosclerotic plaque
and the proximal vessel wall
Tp  difference between the proximal vessel wall
temperature and the maximal temperature
during complete flow interruption and after
balloon deflation
Figure 1. A summary of the sites of temperature measurements for the
computation of Tl (difference between the atherosclerotic plaque and the
proximal vessel wall) and Tp (difference between the proximal vessel wall
temperature and the maximal temperature during complete flow interrup-
tion and after balloon deflation). After recording the temperature at the
proximal vessel wall (PVW) at baseline, three measurements were obtained
at the lesion: 1) at baseline, 2) during coronary flow interruption, and 3)
after balloon deflation. Thus, Tl was obtained at these three phases of the
study. Thereafter, temperature was recorded at the PVW: 1) during
coronary blood flow interruption, and 2) after balloon deflation. The Tp
was obtained at these two phases, respectively.
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All patients were discharged from the hospital with
ticlopidine or clopidogrel for one month, and aspirin,
statins, and standard medical therapy indefinitely.
REPRODUCIBILITY. Duplicate measurements were obtained
in each coronary artery. The data of the first series of
measurements were used for data analysis; the data of the
second measurement were solely used to assess the repro-
ducibility.
Definitions. DIFFERENCE OF TEMPERATURE AT THE LE-
SION (Tl). Difference between the atherosclerotic plaque
and the proximal vessel wall was calculated by subtracting
the temperature at the proximal vessel wall from the
maximal temperature at the lesion at baseline, during
complete occlusion of the flow, and balloon deflation.
DIFFERENCE OF TEMPERATURE AT THE PROXIMAL SEG-
MENT (TP). Difference between the proximal vessel wall
temperature and the maximal temperature during balloon
occlusion and after balloon deflation was calculated by
subtracting the proximal vessel wall temperature from the
maximal temperature during complete occlusion of the flow
and after balloon deflation, respectively.
Quantitative angiographic and coronary volumetric flow
measurements. Quantitative coronary angiographic mea-
surements were performed on-line. A computer-assisted
analysis system was used for quantitative coronary angiog-
raphy (DCI-S, Automated Coronary Analysis, Philips, The
Netherlands). Automated edge-detection of the minimal
lumen diameter and reference diameter were measured by
use of the guiding-catheter filled with contrast as a scaling
factor. The minimal lumen diameter and the percent diam-
eter stenosis were measured in a standard manner. Quanti-
tative angiographic measurements of luminal diameter were
used to calculate coronary cross-sectional area. Coronary
volumetric flow was then calculated as the product of
average peak velocity  0.5 (correction factor assuming
parabolic flow profile)  the cross-sectional area of the
target vessel 5 to 10 mm distal to the Doppler-guidewire tip
location.
Lesions were characterized according to the modified
American College of Cardiology American Heart Associa-
tion classification (9).
Statistical analysis. Continuous variables are presented as
mean  1 standard deviation and qualitative variables as
absolute and relative frequencies. Comparison of Tl at
baseline, during balloon occlusion, and after balloon defla-
tion was performed by analysis of variance for repeated
measurements. Paired t test was used for comparison of
Tp and Tl during flow interruption and after balloon
deflation. Correlation between baseline average peak veloc-
ity with Tl during balloon inflation was performed by
Spearman’s correlation coefficient. All p values are two-
sided and compared to a significant level of 5%. STATA 6
software was used (STATA, College Station, Texas).
RESULTS
Baseline clinical and angiographic characteristics are dem-
onstrated in Tables 1 and 2, respectively. The majority of
the patients were receiving statins 5.3  7.8 months before
the intervention. The procedural characteristics are shown
in Table 2. Flow was obstructed by inflation of the balloon
to 2.5  0.5 atm. The duration of the balloon inflation was
Figure 2. An angiographic frame demonstrating the technique we used. In the proximal part, the balloon (B1) was inflated and temperature was recorded
by the thermistor (Th) located distal to the balloon. The thermography catheter was advanced over a conventional floppy guidewire (GW) 0.014-in. in
diameter. Distally, the Doppler guidewire (D-GW) is shown by which coronary flow velocity was continuously recorded.
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10  2 s. In all cases the procedure was not complicated
neither CK nor CK-MB was elevated after the procedure.
Coronary blood flow measurements. The mean average
peak velocity at baseline and after balloon deflation was
13.06  1.80 cm/s and 23.33  4.87 cm/s, respectively.
After stent implantation, coronary flow velocity was 41.89
 3.32 cm/s. Coronary volumetric flow was increased from
29.23  5.32 ml/min at baseline to 65.62  15.59 ml/min
after stent implantation.
Temperature measurements. Measurements obtained for
determination of proximal vessel wall temperature were
constant in each patient of the total study group, varying by
only 0.02°C, with a standard deviation from 0 to 0.03. The
temperature of the proximal vessel wall and the temperature
of the blood did not differ (p  0.54).
The Tp was 0.012  0.01°C during complete occlusion
of the flow, and after deflation of the balloon it was 0.006
 0.01°C (p  0.001). The Tl was 0.08  0.04°C at
baseline, and it was increased by 60.5  14.1% during
complete occlusion as it was 0.18  0.05°C and 0.08 
0.04°C after balloon deflation (p  0.001) (Fig. 3).
The Tl was greater than Tp during impairment of
flow (p 0.001) and after balloon deflation (p 0.001). At
baseline and after balloon deflation, Tl was not different
(p  0.98). A correlation between the difference of average
peak velocity from baseline values with Tl during flow
interruption was found (R  0.57, p  0.01) (Fig. 4).
In seven patients, thermal heterogeneity was not detected
at baseline (Tl was 0.05°C). However, during balloon
inflation Tl increased by 76.0  8.4% to 0.11  0.02°C,
and immediately after restoration of flow Tl was 0.03 
0.005°C (Fig. 5).
Reproducibility. The second measurements for Tl varied
by only 0.02°C (range 0 to 0.03) at baseline, during balloon
inflation and after balloon deflation. The variation for Tp
was 0.01°C (range 0 to 0.02).
DISCUSSION
The major findings of this study are: 1) thermal heteroge-
neity is underestimated in vivo in stable atheromatic
plaques, and 2) blood flow influences the in vivo tempera-
ture measurements in atheromatic plaques.
Thermal heterogeneity has been detected ex vivo and in
vivo in human atherosclerotic plaques (1,2,10). In the in
vivo studies, however, detected temperature variations were
less compared to ex vivo studies (1,2). Furthermore, in
several significant lesions temperature variations could not
be detected or trivial changes were recorded (1). Especially
in patients with effort angina, only in a minority (20%) of
patients was thermal heterogeneity detected. A significant
factor leading to these diverse results may be the “cooling
effect” of blood flow. Blood flow may increase the heat
transfer from the atherosclerotic plaque; consequently, the
local temperature on the surface of the lesion may be
underestimated.
By complete occlusion of the blood flow, the temperature
difference between the proximal vessel wall, which by
intracoronary ultrasound was free of disease, and the ath-
erosclerotic plaque increased by 60.5%. This increase was
greater (76.0%) in patients with lesions in which, at baseline
measurements, thermal heterogeneity was not detected. The
absolute change in coronary flow velocity was inversely
related to the temperature difference between the athero-
sclerotic plaque and the reference site.
Technical considerations. We used this protocol to inves-
tigate whether thermal heterogeneity exists in all plaques
and to determine the effect of blood flow on temperature
measurements. Advancement of the balloon catheter just
Table 1. Baseline Characteristics
Number 18
Male patients 17 (94%)
Age (yrs) 62  7
Total cholesterol (mg/dl) 214  33
Diabetes mellitus 1 (6%)
Hypertension 9 (50%)
Current smoking 7 (39%)
Family history of CAD 3 (17%)
Beta-blockers 10 (56%)
Aspirin 18 (100%)
Nitrates 12 (67%)
Statin 15 (83%)
ACE inhibitors 12 (67%)
Calcium antagonists 3 (17%)
EF (%) 52  10
Previous PTCA 1 (6%)
Values are mean  SD.
ACE  angiotensin-converting enzyme; CAD  coronary artery disease; EF 
ejection fraction; PTCA  percutaneous transluminal coronary angioplasty.
Table 2. Angiographic Characteristics
Vessel distribution
Left anterior descending artery 9 (50%)
Left circumflex artery 3 (17%)
Right coronary artery 6 (33%)
Location
Proximal 15 (83%)
Middle 3 (17%)
Type of lesion
A 3 (17%)
B1 9 (50%)
B2 6 (33%)
C 0 (0%)
Procedural characteristics
Final maximal diameter (mm) 3.29  0.44
Maximal pressure (atm) 14.08  5.35
Stent length (mm) 16.16  4.83
Balloon/Artery ratio 1.03  0.06
Pre-procedure
Reference (mm) 3.19  0.37
MLD (mm) 0.85  0.26
Stenosis (%) 73.42  7.98
Length of lesion (mm) 10.42  4.21
Post-procedure
MLD (mm) 3.16  0.39
Stenosis (%) 1.01  2.98
MLD  minimal lumen diameter.
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proximal to the thermistor, which was located at the
atherosclerotic plaque, provided, firstly, the ability to com-
pletely occlude the vessel by the inflation of the appropri-
ately selected balloon in terms of size, and, secondly, to
ensure contact of the thermistor with the atherosclerotic
plaque during flow interruption. As the balloon was inflated
just proximal to the site of the lesion, the thermistor was in
contact with the plaque. This is proved by the increase of
temperature in all lesions during the balloon inflation and by
the drop of temperature to baseline values after balloon
deflation. These results were reproducible in the second
series of measurements.
In addition, the effect of flow on these measurements is
clearly demonstrated by the continuous recording of the
flow distal to the lesion, the inverse correlation of blood flow
velocity with the temperature difference at the lesion, and
the unchanged temperature measurements during balloon
inflation in the proximal nondiseased reference segment.
Clinical implications. The results of this study demon-
strate that thermal heterogeneity exists even in stable
plaques and the “cooling effect” of blood flow may lead to
underestimation of in vivo temperature measurements in the
atherosclerotic plaques. This finding may be important as
the identification of plaques with thermal heterogeneity
provides information regarding the local process of inflam-
mation (2,3) and has prognostic value after percutaneous
Figure 3. Difference between the proximal vessel wall temperature and the maximal temperature during complete flow interruption and after balloon
deflation (Tp) (left) and difference of temperature (T) between the atherosclerotic plaque and the proximal vessel wall (Tl) at baseline, during complete
occlusion of flow, and after balloon deflation (right). The bottom of the box represents the first quartile; the top of the box represents the third quartile,
and the line in the box represents the median value of Tp or Tl. The broken vertical line differentiates the measurement for Tp and Tl.
Figure 4. Graph showing the correlation between the difference of average peak velocity (AVP) from baseline values with Tl (difference of temperature
between the atherosclerotic plaque and the proximal vessel wall) during balloon inflation.
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coronary interventions (5). Because dietary (3) or pharma-
cologic (4) interventions may reduce atherosclerotic plaque
temperature, accurate temperature measurements may be
used for the selection of patients for aggressive treatment for
stabilization of plaques potentially prone to rupture and
producing acute ischemic events. Furthermore, blood flow
effect needs to be considered in the evolving technology of
catheter-based or noninvasive techniques for temperature
measurements in human atherosclerotic plaques.
Regarding the safety of the technique, although two
guidewires were used we did not observe any complication
during the procedure. The inflation of the balloon proximal
to the lesion was performed with low pressure and for a
short period of time. Cardiac enzymes were within the
normal limits after the procedure.
Study limitations. The number of patients included in the
study was rather small. The group of patients, however, was
homogeneous regarding the clinical syndrome, the medica-
tion, and the angiographic characteristics. Although the role
of coronary blood flow is revealed in this study we cannot
exclude other potential unknown confounders for the ob-
served increase of atherosclerotic plaque temperature during
obstruction of blood flow.
The effect of blood flow was demonstrated in symptom-
atic patients with angiographically severe stenoses. Interme-
diate or low-grade stenoses in asymptomatic patients could
not be studied with this technique, because incomplete
opposition of the thermistor to these atherosclerotic lesions
due to turbulent flow may lead to underestimation of the
baseline thermal heterogeneity of the plaque. In this study,
however, only lesions producing significant stenoses were
included. The identification of thermal heterogeneity in
nonsignificant stenoses may require a different technology.
Conclusions. Thermal heterogeneity exists in all athero-
sclerotic plaques even in patients with effort angina with
significant stenoses. Potential in vivo underestimation of
heat production locally in human atherosclerotic plaques
with currently available technology is due to the “cooling
effect” of coronary blood flow.
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